MTM & DTP questions with verified answers
Assessing Drug - Related Needs to Identify DTPs
• For each medication, ask yourself:
1. Is the medication _____________? (and are all medical conditions
being ____________?)
2. Is the medication ____________?
3. Is the medication ______?
4. Can the patient ____________? Ans✓✓✓ Indicated, treated
Effective
Safe
Adhere
CMS Guidelines for Part D MTM
• May be provided by _____________ or other qualified ___________
• Must provide CMR ____________ and targeted medication reviews
(TMR) at least _______________
• Must use _____________ process to summarize interaction
- Standardized ________ required (as of 1/1/2013) Ans✓✓✓
Pharmacist, provider
Annually, quarterly
Systemic
Format
,CMS Guidelines for Part D MTM (2017)
Eligibility criteria
• Drug spend in Part D medications: ___________
• Multiple Part D medications: ____ to ____
• Targeted disease states or any chronic disease (___-___) Ans✓✓✓
>3,919
≥ 2 to 8
2-3
CMS Targeted Diseases
Must include at least __ of __:
• Alzheimer's
• ESRD
• HTN
• CHF
• DM
• HLD
• Respiratory disease (including COPD, asthma, other chronic lung
disorders)
• Bone disease/arthritis (osteoporosis, osteoarthritis, rheumatoid
arthritis)
, • Mental health disorders (depression, bipolar disorder, schizophrenia,
other "chronic and disabling disorders") Ans✓✓✓ 5, 9
Components of DTPs
1. An undesirable ________ or _____ of an event experienced by the
patient. The problem can take the form of a medical complaint, sign,
symptom, diagnosis, disease, illness, impairment, disability, abnormal
laboratory value, or syndrome. The event can be the result of
physiological, psychological, sociocultural, or economic conditions.
2. The _____ therapy (products and/ or dosage regimen) associated with
the problem
3. The _________________ that exists (or is suspected to exist) between
the undesirable patient event and drug therapy.
• ______________________ of drug therapy
• Need to ____/_________ drug therapy Ans✓✓✓ Event, risk
Drug
Relationship
Consequence
Add/modify
Consensus Definition
• "MTM is a distinct ______________ or group of services that optimize
therapeutic outcomes for individual patients. MTM services are
Assessing Drug - Related Needs to Identify DTPs
• For each medication, ask yourself:
1. Is the medication _____________? (and are all medical conditions
being ____________?)
2. Is the medication ____________?
3. Is the medication ______?
4. Can the patient ____________? Ans✓✓✓ Indicated, treated
Effective
Safe
Adhere
CMS Guidelines for Part D MTM
• May be provided by _____________ or other qualified ___________
• Must provide CMR ____________ and targeted medication reviews
(TMR) at least _______________
• Must use _____________ process to summarize interaction
- Standardized ________ required (as of 1/1/2013) Ans✓✓✓
Pharmacist, provider
Annually, quarterly
Systemic
Format
,CMS Guidelines for Part D MTM (2017)
Eligibility criteria
• Drug spend in Part D medications: ___________
• Multiple Part D medications: ____ to ____
• Targeted disease states or any chronic disease (___-___) Ans✓✓✓
>3,919
≥ 2 to 8
2-3
CMS Targeted Diseases
Must include at least __ of __:
• Alzheimer's
• ESRD
• HTN
• CHF
• DM
• HLD
• Respiratory disease (including COPD, asthma, other chronic lung
disorders)
• Bone disease/arthritis (osteoporosis, osteoarthritis, rheumatoid
arthritis)
, • Mental health disorders (depression, bipolar disorder, schizophrenia,
other "chronic and disabling disorders") Ans✓✓✓ 5, 9
Components of DTPs
1. An undesirable ________ or _____ of an event experienced by the
patient. The problem can take the form of a medical complaint, sign,
symptom, diagnosis, disease, illness, impairment, disability, abnormal
laboratory value, or syndrome. The event can be the result of
physiological, psychological, sociocultural, or economic conditions.
2. The _____ therapy (products and/ or dosage regimen) associated with
the problem
3. The _________________ that exists (or is suspected to exist) between
the undesirable patient event and drug therapy.
• ______________________ of drug therapy
• Need to ____/_________ drug therapy Ans✓✓✓ Event, risk
Drug
Relationship
Consequence
Add/modify
Consensus Definition
• "MTM is a distinct ______________ or group of services that optimize
therapeutic outcomes for individual patients. MTM services are
